|
US6184344B1
(en)
*
|
1995-05-04 |
2001-02-06 |
The Scripps Research Institute |
Synthesis of proteins by native chemical ligation
|
|
US6849428B1
(en)
*
|
1997-03-05 |
2005-02-01 |
New England Biolabs, Inc. |
Intein-mediated protein ligation of expressed proteins
|
|
ATE285415T1
(de)
*
|
1997-06-13 |
2005-01-15 |
Gryphon Therapeutics Inc |
Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen
|
|
EP1009757A1
(en)
|
1997-09-04 |
2000-06-21 |
Gryphon Sciences |
Modular protein libraries and methods of preparation
|
|
AUPP589598A0
(en)
|
1998-09-14 |
1998-10-08 |
University Of Queensland, The |
Novel peptides
|
|
US7001745B1
(en)
*
|
1998-09-30 |
2006-02-21 |
New England Biolabs, Inc. |
Intein mediated peptide ligation
|
|
CN1350544A
(zh)
*
|
1999-03-11 |
2002-05-22 |
格莱风科学公司 |
可溶性膜蛋白受体结构域的化学合成及应用
|
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
US20040014082A1
(en)
*
|
2000-08-11 |
2004-01-22 |
Invitrogen Corporation |
Highly homogeneous molecular markers for electrophoresis
|
|
JP2004506221A
(ja)
*
|
2000-08-11 |
2004-02-26 |
インヴィトロジェン コーポレーション |
高度に均一な電気泳動用分子マーカー
|
|
KR20030046389A
(ko)
*
|
2000-09-01 |
2003-06-12 |
그리폰 테라퓨틱스, 인코포레이티드 |
친핵체에 안정한 티오에스테르 발생 화합물, 제조 및 사용방법
|
|
WO2002057294A2
(en)
*
|
2001-01-22 |
2002-07-25 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for dna binding and gene regulation in plants
|
|
EP1412517B1
(en)
*
|
2001-03-09 |
2006-11-29 |
Boston Probes, Inc. |
Methods, kits and compositions of combination oligomers
|
|
GB0113657D0
(en)
*
|
2001-06-05 |
2001-07-25 |
Geneprot Inc |
Improved native chemical ligation with three or more components
|
|
EP2042196B1
(en)
|
2001-10-10 |
2016-07-13 |
ratiopharm GmbH |
Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
|
|
ES2340376T3
(es)
*
|
2002-06-10 |
2010-06-02 |
Amylin Pharmaceuticals, Inc. |
Desproteccion del azufre posterior a la escision para la sintesis convergente de proteinas mediante ligacion quimica.
|
|
JP2005531616A
(ja)
*
|
2002-06-29 |
2005-10-20 |
アクヴァノヴァ・ジャーマン・ソリュービリセイト・テクノロジーズ・（アーゲーテー）・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
イソフラボン濃縮物およびその製造法
|
|
US7598224B2
(en)
|
2002-08-20 |
2009-10-06 |
Biosurface Engineering Technologies, Inc. |
Dual chain synthetic heparin-binding growth factor analogs
|
|
US8227411B2
(en)
|
2002-08-20 |
2012-07-24 |
BioSurface Engineering Technologies, Incle |
FGF growth factor analogs
|
|
US7166574B2
(en)
*
|
2002-08-20 |
2007-01-23 |
Biosurface Engineering Technologies, Inc. |
Synthetic heparin-binding growth factor analogs
|
|
WO2004053460A2
(en)
*
|
2002-12-11 |
2004-06-24 |
New England Biolabs, Inc. |
Carrier-ligand fusions and uses thereof
|
|
US8034900B2
(en)
|
2002-12-30 |
2011-10-11 |
Amylin Pharmaceuticals, Inc. |
Water-soluble thioester and selenoester compounds and methods for making and using the same
|
|
EP2055189A1
(en)
|
2003-04-09 |
2009-05-06 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
PT1624891E
(pt)
|
2003-05-06 |
2010-01-05 |
Syntonix Pharmaceuticals Inc |
Proteínas quiméricas de factor de coagulação-fc destinadas ao tratamento da hemofilia
|
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
TWI353991B
(en)
*
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
WO2004105685A2
(en)
*
|
2003-05-22 |
2004-12-09 |
Gryphon Therapeutics, Inc. |
Displaceable linker solid phase chemical ligation
|
|
US7414028B1
(en)
|
2004-02-04 |
2008-08-19 |
Biosurface Engineering Technologies, Inc. |
Growth factor analogs
|
|
US7528105B1
(en)
|
2004-02-10 |
2009-05-05 |
Biosurface Engineering Technologies |
Heterodimeric chain synthetic heparin-binding growth factor analogs
|
|
US7671012B2
(en)
|
2004-02-10 |
2010-03-02 |
Biosurface Engineering Technologies, Inc. |
Formulations and methods for delivery of growth factor analogs
|
|
US20080227696A1
(en)
|
2005-02-22 |
2008-09-18 |
Biosurface Engineering Technologies, Inc. |
Single branch heparin-binding growth factor analogs
|
|
US20060024347A1
(en)
*
|
2004-02-10 |
2006-02-02 |
Biosurface Engineering Technologies, Inc. |
Bioactive peptide coatings
|
|
ATE482228T1
(de)
|
2004-02-20 |
2010-10-15 |
Biosurface Eng Tech Inc |
Positiver modulator des knochenmorphogenetisches protein-2 (bmp-2)
|
|
RU2413731C2
(ru)
|
2004-04-09 |
2011-03-10 |
Чугаи Сейяку Кабусики Кайся |
Новые растворимые в воде пролекарства
|
|
WO2005115433A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Rigel Pharmaceuticals, Inc. |
Methods for cyclizing synthetic polymers
|
|
EP2258382A3
(en)
|
2005-03-31 |
2014-05-14 |
Amylin Pharmaceuticals, LLC |
Amylin and amylin agonists for treating psychiatric diseases and disorders
|
|
TW200744603A
(en)
|
2005-08-22 |
2007-12-16 |
Chugai Pharmaceutical Co Ltd |
Novel anticancer concomitant drug
|
|
US7674881B2
(en)
*
|
2005-10-07 |
2010-03-09 |
The University Of Chicago |
Convergent synthesis of proteins by kinetically controlled ligation
|
|
CA2626330A1
(en)
*
|
2005-10-19 |
2007-04-26 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive or therapeutic agents for pancreatic cancer, ovarian cancer, or liver cancer comprising a novel water-solube prodrug
|
|
US7820172B1
(en)
|
2006-06-01 |
2010-10-26 |
Biosurface Engineering Technologies, Inc. |
Laminin-derived multi-domain peptides
|
|
JP2009541358A
(ja)
|
2006-06-22 |
2009-11-26 |
バイオサーフェス エンジニアリング テクノロジーズ，インク． |
骨形成を強化するためにｂｍｐ−２増幅因子／共活性化因子を送達するための組成物および方法
|
|
EP2120985B1
(en)
|
2007-02-05 |
2012-06-27 |
Amylin Pharmaceuticals, Inc. |
FN-38 peptides for use in the treatment of psychotic and anxiety disorders
|
|
JP2010537984A
(ja)
*
|
2007-08-28 |
2010-12-09 |
イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ |
ポリペプチドおよび蛋白質の化学合成のための方法および中間体
|
|
WO2011103409A1
(en)
*
|
2010-02-18 |
2011-08-25 |
Advanced Proteome Therapeutics Inc. |
Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides
|
|
WO2012050923A2
(en)
|
2010-09-28 |
2012-04-19 |
Amylin Pharmaceuticals, Inc. |
Engineered polypeptides having enhanced duration of action
|
|
ES2630031T3
(es)
|
2010-09-28 |
2017-08-17 |
Aegerion Pharmaceuticals, Inc. |
Un polipéptido de leptina pinnípedo-humano quimérico con solubilidad aumentada
|
|
ES2732475T3
(es)
|
2011-07-08 |
2019-11-22 |
Aegerion Pharmaceuticals Inc |
Polipéptidos modificados por ingeniería genética que tienen una duración potenciada de la acción y una inmunogenicidad reducida
|
|
JP6006309B2
(ja)
|
2011-07-08 |
2016-10-12 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
|
|
FR2981352B1
(fr)
*
|
2011-10-17 |
2015-07-03 |
Centre Nat Rech Scient |
Procede de synthese de proteines
|
|
CA2873112A1
(en)
|
2012-05-11 |
2013-11-14 |
Alexander Krantz |
Site-specific labeling and targeted delivery of proteins for the treatment of cancer
|
|
US9731029B2
(en)
|
2012-05-21 |
2017-08-15 |
Massachusetts Institute Of Technology |
Protein retrosplicing enabled by a double ligation reaction
|
|
AR095527A1
(es)
|
2013-03-15 |
2015-10-21 |
Biogen Idec Inc |
Formulaciones de polipéptido fc-factor ix
|
|
US11273176B2
(en)
|
2016-03-02 |
2022-03-15 |
The Brigham And Women's Hospital, Inc. |
Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation
|
|
KR102544146B1
(ko)
|
2017-03-02 |
2023-06-15 |
가부시키가이샤 도우사 고가쿠 겐큐쇼 |
아미노산 중합체의 제조방법
|
|
CN113166196A
(zh)
|
2018-10-01 |
2021-07-23 |
日内瓦大学 |
用于生成适合生物学分析的多种多肽变体的方法
|
|
JP7281826B2
(ja)
*
|
2018-11-30 |
2023-05-26 |
株式会社糖鎖工学研究所 |
ペプチドチオエステル、ペプチドの新規製造方法
|
|
AU2020361681A1
(en)
|
2019-10-10 |
2022-05-05 |
1859, Inc. |
Methods and systems for microfluidic screening
|
|
CN110945009B
(zh)
*
|
2019-10-23 |
2023-10-31 |
烟台迈百瑞国际生物医药股份有限公司 |
一种寡肽连接子中间体及其制备方法
|
|
WO2022266467A2
(en)
|
2021-06-17 |
2022-12-22 |
Dana-Farber Cancer Institute, Inc. |
Recombinant histone polypeptide and uses thereof
|
|
EP4646232A1
(en)
|
2023-01-06 |
2025-11-12 |
Université de Genève |
Variant ligand conjugates for payload delivery
|